These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35013115)

  • 1. Tumor-derived extracellular vesicles inhibit HGF/c-Met and EGF/EGFR pathways to accelerate the radiosensitivity of nasopharyngeal carcinoma cells via microRNA-142-5p delivery.
    Zhu C; Jiang X; Xiao H; Guan J
    Cell Death Discov; 2022 Jan; 8(1):17. PubMed ID: 35013115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PVT1 Mediates Cell Proliferation, Apoptosis and Radioresistance in Nasopharyngeal Carcinoma Through Regulating miR-515-5p/PIK3CA Axis.
    Han Y; Li F; Xie J; Wang Y; Zhang H
    Cancer Manag Res; 2020; 12():10077-10090. PubMed ID: 33116864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cell proliferation and radioresistance by miR-383-5p through targeting RNA binding protein motif (RBM3) in nasopharyngeal carcinoma.
    Ma R; Gao P; Yang H; Hu J; Xiao JJ; Shi M; Zhao LN
    Ann Transl Med; 2021 Jan; 9(2):123. PubMed ID: 33569425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular vesicles derived from paclitaxel-sensitive nasopharyngeal carcinoma cells deliver miR-183-5p and impart paclitaxel sensitivity through a mechanism involving P-gp.
    Cui X; Chen Y; Zhao L; Ding X
    Cell Biol Toxicol; 2023 Dec; 39(6):2953-2970. PubMed ID: 37296288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxic tumour cell-derived exosomal miR-340-5p promotes radioresistance of oesophageal squamous cell carcinoma via KLF10.
    Chen F; Xu B; Li J; Yang X; Gu J; Yao X; Sun X
    J Exp Clin Cancer Res; 2021 Jan; 40(1):38. PubMed ID: 33485367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes overexpressing miR-34c inhibit malignant behavior and reverse the radioresistance of nasopharyngeal carcinoma.
    Wan FZ; Chen KH; Sun YC; Chen XC; Liang RB; Chen L; Zhu XD
    J Transl Med; 2020 Jan; 18(1):12. PubMed ID: 31915008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA-17 promotes nasopharyngeal carcinoma radioresistance by targeting PTEN/AKT.
    Hu Z; Zhou S; Luo H; Ji M; Zheng J; Huang F; Wang F
    Int J Clin Exp Pathol; 2019; 12(1):229-240. PubMed ID: 31933738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis.
    Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X
    J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PADI4, negatively regulated by miR-335-5p, participates in regulating the proliferation, migration, invasion and radiosensitivity of nasopharyngeal carcinoma cells.
    Wei LN; Luo M; Wang XP; Liang T; Huang CJ; Chen H
    J Biol Regul Homeost Agents; 2021; 35(1):117-129. PubMed ID: 33593046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-449b-5p suppresses cell proliferation, migration and invasion by targeting TPD52 in nasopharyngeal carcinoma.
    Yin W; Shi L; Mao Y
    J Biochem; 2019 Nov; 166(5):433-440. PubMed ID: 31350893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferation, Metastasis, and Radiosensitivity of Nasopharyngeal Carcinoma Cells in the Expression and Effect of Kiwifruit Extract through the Regulation of miR-205-5p.
    Chen Q; Pan M; Lu Y; Wei F; Chen C; Huang H
    J Oncol; 2022; 2022():6925772. PubMed ID: 35990993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC00114 promoted nasopharyngeal carcinoma progression and radioresistance in vitro and in vivo through regulating ERK/JNK signaling pathway via targeting miR-203.
    Han YY; Liu K; Xie J; Li F; Wang Y; Yan B
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2491-2504. PubMed ID: 32196600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-96-5p Suppresses the Progression of Nasopharyngeal Carcinoma by Targeting CDK1.
    Luo X; He X; Liu X; Zhong L; Hu W
    Onco Targets Ther; 2020; 13():7467-7477. PubMed ID: 32801769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-378g enhanced radiosensitivity of NPC cells partially by targeting protein tyrosine phosphatase SHP-1.
    Lin T; Zhou F; Zhou H; Pan X; Sun Z; Peng G
    Int J Radiat Biol; 2015; 91(11):859-66. PubMed ID: 26473472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-181a Upregulation Promotes Radioresistance of Nasopharyngeal Carcinoma by Targeting RKIP.
    Huang W; Liu J; Hu S; Shi G; Yong Z; Li J; Qiu J; Cao Y; Yuan L
    Onco Targets Ther; 2019; 12():10873-10884. PubMed ID: 31849491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-138-5p controls sensitivity of nasopharyngeal carcinoma to radiation by targeting EIF4EBP1.
    Gao W; Lam JW; Li JZ; Chen SQ; Tsang RK; Chan JY; Wong TS
    Oncol Rep; 2017 Feb; 37(2):913-920. PubMed ID: 28075468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-129-5p suppresses nasopharyngeal carcinoma lymphangiogenesis and lymph node metastasis by targeting ZIC2.
    Yu D; Han GH; Zhao X; Liu X; Xue K; Wang D; Xu CB
    Cell Oncol (Dordr); 2020 Apr; 43(2):249-261. PubMed ID: 31884576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of lncRNA X Inactive Specific Transcript (XIST) Suppresses Cell Proliferation and Enhances Radiosensitivity by Upregulating mir-29c in Nasopharyngeal Carcinoma Cells.
    Han Q; Li L; Liang H; Li Y; Xie J; Wang Z
    Med Sci Monit; 2017 Oct; 23():4798-4807. PubMed ID: 28985197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHAF1B induces radioresistance by promoting DNA damage repair in nasopharyngeal carcinoma.
    Di M; Wang M; Miao J; Chen B; Huang H; Lin C; Jian Y; Li Y; Ouyang Y; Chen X; Wang L; Zhao C
    Biomed Pharmacother; 2020 Mar; 123():109748. PubMed ID: 31869663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-212-5p inhibits nasopharyngeal carcinoma progression by targeting METTL3.
    Zhou H; Zhang N
    Open Med (Wars); 2022; 17(1):1241-1251. PubMed ID: 35892080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.